Christoph Ruwwe‐Glösenkamp

Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans

Petra Bächer, Thordis Hohnstein, Eva Beerbaum et al. · Cell · 2019 · 454 citations

Antifungal Agent, Microbial Pathogens, Candida Albicans +5

A time-resolved proteomic and prognostic map of COVID-19

Vadim Demichev, Pinkus Tober‐Lau, Oliver Lemke et al. · Cell Systems · 2021 · 212 citations · Full text

Accredited Diagnostic Parameters, Prognosis, Immunology +17

Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19)

Florian Kurth, Maria Roennefarth, Charlotte Thibeault et al. · Infection · 2020 · 110 citations · Full text

Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months

Fridolin Steinbeis, Charlotte Thibeault, Felix Doellinger et al. · Respiratory Medicine · 2021 · 105 citations · Full text

Observational Longitudinal Study, Respiratory Diseases, Covid-19 Pandemic +9

CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity

Jan-Moritz Doehn, Christoph Tabeling, Robert Biesen et al. · Infection · 2021 · 70 citations · Full text